CHU Montpellier — Montpellier

Public research footprint of CHU Montpellier, compiled from the ClinicalTrials.gov public registry.

557

Registered studies

218

Active

127

Recruiting now

231

Completed

Stopped or withdrawn

Most-studied conditions

Type 1 Diabetes · Non-small Cell Lung Cancer · Diffuse Large B Cell Lymphoma · Chronic Lymphocytic Leukemia

Recently updated registry entries

NCT07317102 — Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) (Recruiting)
NCT07015983 — A Study of CC-97540 (BMS-986353 or Zola-cel), CD19-Targeted NEX-T CAR T Cells, in… (Active Not Recruiting)
NCT06571149 — Safety and Efficacy of Intravenous Thrombolysis in Patients With Ischemic Stroke and… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at CHU Montpellier?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.